Exhibit 10.1
$15,000,000
CENTRAL PACIFIC FINANCIAL
CORP.
Common Stock, no par value per
share
Distribution
Agreement
September 4, 2009
Sandler O’Neill & Partners,
L.P.,
919 Third Avenue, 6th Floor,
New York, New York 10022
RBC Capital Markets Corporation,
3 World Financial Center,
200 Vesey Street, 8th Floor,
New York, New York 10006
Ladies and Gentlemen:
Central Pacific Financial Corp., a
Hawaii corporation (the “ Company ”), proposes
to issue and sell from time to time to or through Sandler
O’Neill & Partners, L.P. (“ Sandler
O’Neill & Partners ”) and RBC Capital
Markets Corporation (“ RBC Capital Markets ”),
as sales agents and/or principals (the “ Agents
”), shares of the Company’s common stock, without par
value (the “ Common Stock ”) having
aggregate sales proceeds of up to $15,000,000, on the terms set
forth in this Distribution Agreement (this “ Agreement
”). For the purposes of this Agreement, shares of
Common Stock to be sold under this Agreement shall be referred to
as “ Shares .” The Company agrees that
whenever it determines to sell Shares directly to either of the
Agents, as principals, it will enter into a separate agreement
(each, a “ Terms Agreement ”) with such Agent,
in substantially the form of Annex I hereto, relating to such
sale.
Section 1.
Representations and
Warranties . The
Company represents and warrants to the Agents that, as of the date
of this Agreement, any applicable Registration Statement Amendment
Date (as defined in Section 3(i) below), each Company
Periodic Report Date (as defined in Section 3(h) below),
each Applicable Time (as defined in
Section 1(a) below) and each Settlement Date (as
defined in Section 2(g) below):
(a)
The Company has filed with the
Securities and Exchange Commission (the “ Commission
”) a registration statement on Form S-3
(Registration No. 333-157166) for the registration of the
Shares and other securities of the Company, which registration
statement has been declared effective by the Commission under the
Securities Act of 1933, as amended (the “ 1933 Act
”), in respect of the Shares; and no stop order suspending
the effectiveness of such registration statement or any part
thereof has been issued and no proceeding for that purpose has been
initiated or, to the knowledge of the Company, threatened by the
Commission, and no
1
written (or, to the knowledge of the Company,
oral) notice of objection of the Commission to the use of such
form of registration statement or any post-effective amendment
thereto has been received by the Company (the base prospectus filed
as part of such registration statement, in the form in which it has
most recently been filed with the Commission on or prior to the
date of this Agreement, is hereinafter called the “ Basic
Prospectus ”; the various parts of such registration
statement, and any prospectus supplement relating to the Shares
that is filed with the Commission and deemed by virtue of
Rule 430B under the 1933 Act to be part of such registration
statement, each as amended at the time such part of the
registration statement became effective, are hereinafter
collectively called the “ Registration Statement
”; the prospectus supplement specifically relating to the
Shares prepared and filed with the Commission pursuant to
Rule 424(b) under the 1933 Act is hereinafter called the
“ Prospectus Supplement ”; the Basic Prospectus,
as amended and supplemented by the Prospectus Supplement, is
hereinafter called the “ Prospectus ”; any
reference herein to the Basic Prospectus, the Prospectus Supplement
or the Prospectus shall be deemed to refer to and include the
documents incorporated by reference therein pursuant to Item 12 of
Form S-3 under the 1933 Act; any reference to any amendment or
supplement to the Basic Prospectus, the Prospectus Supplement or
the Prospectus shall be deemed to refer to and include any
post-effective amendment to the Registration Statement, any
prospectus supplement relating to the Shares filed with the
Commission pursuant to Rule 424(b) under the 1933 Act and
any documents filed under the Securities Exchange Act of 1934, as
amended (the “ 1934 Act ”), and incorporated
therein, in each case after the date of the Basic Prospectus, the
Prospectus Supplement or the Prospectus, as the case may be; any
reference to any amendment to the Registration Statement shall be
deemed to refer to and include any annual report of the Company
filed pursuant to Section 13(a) or 15(d) of the 1934
Act after the effective date of the Registration Statement that is
incorporated by reference in the Registration Statement; and any
“issuer free writing prospectus” as defined in
Rule 433 under the 1933 Act relating to the Shares is
hereinafter called an “ Issuer Free Writing Prospectus
”).
At the respective times the
Registration Statement was originally declared effective and any
amendment thereto was declared effective, at the time the
Company’s most recent Annual Report on Form 10-K was
filed with the Commission, at each “new effective date”
with respect to the Agents pursuant to Rule 430B(f)(2) of
the rules and regulations of the Commission under the 1933 Act
(the “ 1933 Act Regulations ”), the Registration
Statement and any amendments thereto complied, comply and will
comply in all material respects with the requirements of the 1933
Act and the 1933 Act Regulations and did not, do not and will not
contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make
the statements therein not misleading.
No order preventing or suspending
the use of the Basic Prospectus, the Prospectus Supplement, the
Prospectus or any Issuer Free Writing Prospectus has been issued by
the Commission, and the Basic Prospectus and the Prospectus
Supplement, at the time of filing thereof, conformed in all
material respects to the requirements of the 1933 Act and the 1933
Act Regulations and did not contain an untrue statement of a
material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not
misleading.
For the purposes of this Agreement,
the “ Applicable Time ” means, with respect to
any Shares, the time of sale of such Shares pursuant to this
Agreement; the Prospectus and the
2
applicable Issuer Free Writing
Prospectus(es) issued at or prior to such Applicable Time,
taken together (collectively, and, with respect to any Shares,
together with the public offering price of such Shares, the “
General Disclosure Package ”) as of each
Applicable Time and each Settlement Date, will not include any
untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not
misleading; and each applicable Issuer Free Writing Prospectus will
not conflict with the information contained in the Registration
Statement, the Prospectus Supplement or the Prospectus, and each
such Issuer Free Writing Prospectus, as supplemented by and taken
together with the General Disclosure Package as of such Applicable
Time, will not include any untrue statement of a material fact or
omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances under which
they were made, not misleading.
(b)
The documents incorporated or deemed
to be incorporated by reference in the Prospectus Supplement or the
Prospectus, at the respective time they were or hereafter are filed
with the Commission, complied, comply and will comply in all
material respects with the requirements of the 1934 Act and the
rules and regulations of the Commission thereunder (the
“ 1934 Act Regulations ”), and did not, do not
and will not contain an untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary
in order to make the statements therein, in light of the
circumstances under which they were made, not
misleading.
(c)
The statements set forth in the
Prospectus Supplement under the captions “Risk Factors
— Risks Related to this Offering”, “Description
of Common Stock” and “Plan of Distribution” and
in the Company’s Form 8-A filed with the Commission on
December 12, 2002, as amended, insofar as they purport to
constitute a summary of the terms of the Shares or certain
provisions of the Company’s charter and by-laws or Hawaii
law, and in the Basic Prospectus under the caption “Our
Company - Supervision and Regulation”, in the Prospectus
Supplement under the caption “Certain United States Tax
Consequences to Non-U. S. Holders of Our Common Stock” and in
the Company’s Annual Report on Form 10-K for the year
ended December 31, 2008 under the caption “Supervision
and Regulation”, insofar as they purport to describe the
provisions of the laws, rules, regulations and documents referred
to therein, are accurate in all material respects and represent a
fair summary of such terms or provisions, as applicable.
(d)
The Company is a corporation duly
incorporated, validly existing and in good standing under the laws
of the State of Hawaii and the Company is qualified to do business
as a foreign corporation in each jurisdiction in which
qualification is required, except where failure to so qualify would
not have a Material Adverse Effect (as defined below). Each
of the Company’s subsidiaries that is a “significant
subsidiary” as defined in Rule 1-02 of Regulation S-X
(each a “ Subsidiary ” and collectively the
“ Subsidiaries ”) is listed on
Exhibit 21 to the Company’s most recent Annual Report on
Form 10-K/A filed with the Commission. Except as
otherwise stated on Exhibit 21, each Subsidiary is a direct or
indirect wholly owned subsidiary of the Company. Each
Subsidiary is duly incorporated, validly existing and in good
standing under the laws of its jurisdiction of incorporation and is
qualified to do business as a foreign corporation in each
jurisdiction in which qualification is required, except where
failure to so qualify would not have a Material Adverse
Effect. For the purposes of this Agreement, the
term
3
“ Material Adverse Effect ”
shall mean a material adverse effect on the business, financial
condition, properties, shareholder’s equity, or results of
operations of the Company and its Subsidiaries, taken as a
whole.
(e)
The Company is duly registered as a
bank holding company under the Bank Holding Company Act of 1956, as
amended. The Company’s banking subsidiary holds the
requisite authority from the Hawaii Division of Financial
Institutions (the “ Division ”) to do
business as a state-chartered banking corporation under the laws of
the State of Hawaii as described in each of the General Disclosure
Package and the Prospectus. The Company and each Subsidiary
are in compliance in all material respects with all laws
administered by the Board of Governors of the Federal Reserve
System (the “ Federal Reserve Board ”), the
Federal Deposit Insurance Corporation (the “ FDIC
”), the Division and any other federal or state bank
regulatory authorities with jurisdiction over the Company and its
subsidiaries, except for failures to be so in compliance that would
not, individually or in the aggregate, reasonably be expected to
have a Material Adverse Effect.
(f)
The Company is subject to the
reporting requirements of the 1934 Act and has timely filed all
reports required thereby.
(g)
The Company has the authorized
capitalization set forth in the Prospectus. All of the issued
shares of capital stock of the Company have been duly and validly
authorized and issued, are fully paid and nonassessable, have been
issued in compliance with all federal and state securities laws,
and were not issued in violation of or subject to any preemptive
rights or other similar rights, except for such rights as may have
been fully satisfied or waived. Except as disclosed in the
Prospectus and for options, restricted stock, restricted stock
units and similar securities issued under the Company’s
existing shareholder-approved equity compensation plans, the
Company does not have outstanding any options to purchase, or any
preemptive rights or other rights to subscribe for or to purchase,
any securities or obligations convertible into, or any contracts or
commitments to issue or sell, shares of its capital stock or any
such options, rights, convertible securities or obligations.
With respect to each of the Subsidiaries, all the issued and
outstanding shares of such Subsidiary’s capital stock have
been duly authorized and validly issued, are fully paid and
nonassessable, and, except as disclosed in the Prospectus, are
owned directly by the Company or one of its Subsidiaries free and
clear of any liens, claims or encumbrances, other than the pledge
of the capital of CPB Real Estate, Inc. to the Federal Home
Loan Bank.
(h)
The Shares have been duly authorized
and, when issued, delivered and paid for in the manner set forth in
this Agreement, will be validly issued, fully paid and
nonassessable, and conform in all material respects to the
description thereof contained in each of the Registration
Statement, the General Disclosure Package and the Prospectus.
No preemptive rights or other rights to subscribe for or purchase
any shares of Common Stock exist with respect to the issuance and
sale of the Shares by the Company pursuant to this Agreement,
except for such rights as may have been fully satisfied or waived
prior to the Settlement Date. There are no restrictions upon
the voting or transfer of any of the Shares except as required
under applicable federal or state securities laws. No further
approval or authority of the shareholders or the Board of Directors
of the Company will be required for the issuance and sale of the
Shares as contemplated herein.
4
(i)
The Company has full legal right,
corporate power and authority to enter into this Agreement and
perform the transactions contemplated hereby. This Agreement
has been duly authorized, executed and delivered by the
Company. This Agreement constitutes a legal, valid and
binding agreement of the Company, enforceable against the Company
in accordance with its terms, except as enforceability may be
limited by applicable bankruptcy, insolvency, reorganization,
moratorium or other laws of general application relating to or
affecting the enforcement of creditors’ rights and the
application of equitable principles relating to the availability of
remedies, and subject to 12 U.S.C. §1818(b)(6)(D) (or any
successor statute) and similar bank regulatory powers and to
the application of principles of public policy, and except as
rights to indemnity or contribution, including but not limited to,
indemnification provisions set forth in Section 7 of this
Agreement may be limited by federal or state securities law or the
public policy underlying such laws.
(j)
KPMG LLP, who has expressed its
opinion with respect to the consolidated financial statements
contained in the Company’s Annual Report on Form 10-K/A
for the year ended December 31, 2008, are registered
independent public accountants as required by the 1933 Act and the
1933 Act Regulations and by the rules of the Public Accounting
Oversight Board and, to the knowledge of the Company after
reasonable inquiry, KPMG is not in violation of the auditor
independence requirements of the Sarbanes-Oxley Act of 2002 with
respect to the Company.
(k)
The execution, delivery and
performance of this Agreement by the Company, the issuance and sale
of the Shares by the Company, the compliance by the Company with
all of the provisions of this Agreement and the consummation of the
transactions herein contemplated (including, without limitation,
the use of proceeds from the sale of the Shares as described in the
Prospectus Supplement and the Prospectus under the caption
“Use of Proceeds”), do not and will not
(i) violate or conflict with any provision of the amended and
restated articles of incorporation or bylaws of the Company or the
organizational documents of any Subsidiary and (ii) except as
would not reasonably be expected to result in a Material Adverse
Effect and will not materially and adversely affect the
Company’s ability to consummate the transactions contemplated
by this Agreement, (x) result in the creation of any lien,
charge, security interest or encumbrance upon any assets of the
Company or any Subsidiary pursuant to the terms or provisions of,
and will not conflict with, result in the breach or violation of,
or constitute, either by itself or upon notice or the passage of
time or both, a default under, or give rise to the accelerated due
date of any payment due under, any agreement, mortgage, deed of
trust, lease, franchise, license, indenture, permit or other
instrument to which any of the Company or any Subsidiary is a party
or by which any of the Company or any Subsidiary or their
respective properties may be bound or affected or (y) violate
any statute or any authorization, judgment, decree, order,
rule or regulation of any court or any regulatory body,
administrative agency or other governmental agency or body
applicable to the Company or any Subsidiary or any of their
respective properties. All consents, approvals, licenses,
qualifications, authorizations or other orders of any court,
regulatory body, administrative agency or other governmental agency
or body that are required for the execution and delivery of this
Agreement or the consummation of the transactions contemplated by
this Agreement, including the issuance, sale and delivery of the
Shares, have been obtained, except such consents, approvals
authorizations, registrations or qualifications as may be required
under state securities or Blue Sky laws in connection with the
purchase and distribution of the Shares by the Agents.
5
(l)
Except as would not reasonably be
expected to have a Material Adverse Effect, the material contracts
to which the Company or any of its Subsidiaries is a party, have
been duly and validly authorized, executed and delivered by the
Company or its Subsidiaries, as the case may be, and constitute the
legal, valid and binding agreements of the Company or its
Subsidiaries, enforceable by and against it in accordance with
their respective terms, except as such enforceability may be
limited by applicable bankruptcy, insolvency, reorganization or
other similar laws relating to enforcement of creditors’
rights generally, and general equitable principles relating to the
availability of remedies, and subject to 12 U.S.C.
§1818(b)(6)(D) (or any successor statute) and
similar bank regulatory powers and to the application of principles
of public policy, and except as rights to indemnity or contribution
may be limited by federal or state securities laws and the public
policy underlying such laws.
(m)
The deposit accounts of the Central
Pacific Bank (the “ Bank ”) are insured up
to the maximum amount provided by the FDIC and no proceedings for
the modification, termination or revocation of any such insurance
are pending or threatened.
(n)
Except as disclosed in each of the
General Disclosure Package and the Prospectus, there are no legal
or governmental actions, suits or proceedings pending or, to the
Company’s knowledge, threatened against the Company or any
Subsidiary before or by any court, regulatory body or
administrative agency or any other governmental agency or body,
domestic, or foreign, which actions, suits or proceedings,
individually or in the aggregate, would reasonably be expected to
have a Material Adverse Effect; and no labor disturbance by the
employees of the Company exists or, to the Company’s
knowledge, is imminent, that would reasonably be expected to have a
Material Adverse Effect.
(o)
Except as disclosed in each of the
General Disclosure Package and the Prospectus, no Subsidiary of the
Company is currently prohibited, directly or indirectly, under any
order of the Federal Reserve Board (other than orders applicable to
bank holding companies and their subsidiaries generally), under any
applicable law, or under any agreement or other instrument to which
it is a party or is subject, from paying any dividends to the
Company , from making any other distribution on such
Subsidiary’s capital stock (other than as provided in the
(x) Indenture, dated December 15, 2004, by and between
the Company, as issuer, and Wilmington Trust Company, as trustee,
and (y) Indenture, dated October 10, 2003, by and between
the Company, as issuer, and U.S. Bank National Association, as
trustee), from repaying to the Company any loans or advances to
such Subsidiary from the Company or from transferring any of such
Subsidiary’s properties or assets to the Company or any other
Subsidiary of the Company.
(p)
Each of the Company and its
Subsidiaries has valid title to all the properties and assets
described as owned by it in the consolidated financial statements
included in the Registration Statement, the General Disclosure
Package and the Prospectus, free and clear of all liens, mortgages,
pledges, or encumbrances of any kind except (i) those, if any,
reflected in such consolidated financial statements, or
(ii) those that would not reasonably be expected to have a
Material Adverse Effect. Any real property and buildings held
under lease or sublease by the Company and each of its Subsidiaries
are held by them under valid, subsisting and enforceable
leases.
6
(q)
Except as disclosed in each of the
General Disclosure Package and the Prospectus, since
December 31, 2008, (i) the Company and its Subsidiaries
have conducted their respective businesses in all material respects
in the ordinary course, consistent with prior practice,
(ii) except for publicly disclosed ordinary dividends on the
Common Stock and dividends paid on the Company’s Fixed Rate
Cumulative Perpetual Preferred Stock, the Company has not made or
declared any distribution in cash or in kind to its shareholders,
(iii) neither the Company nor any of its Subsidiaries has
issued any capital stock or securities issuable into capital stock
except for securities issued pursuant to the Company’s
existing shareholder-approved equity incentive plans,
(iv) neither the Company nor its Subsidiaries has incurred any
liabilities or obligations of any nature (absolute, accrued,
contingent or otherwise) which are not fully reflected or
reserved against in the financial statements described in
Section 1(cc), except for liabilities that have arisen since
such date in the ordinary and usual course of business and
consistent with past practice and that, individually or in the
aggregate, have not had and would not reasonably be expected to
have a Material Adverse Effect and (v) no event or events have
occurred that, individually or in the aggregate, has had or would
reasonably be expected to have a Material Adverse Effect. As
used in this paragraph, references to the General Disclosure
Package and the Prospectus exclude any amendments or supplements
thereto subsequent to the date of this Agreement.
(r)
The Company owns, is licensed or
otherwise possesses all rights to use, all patents, patent rights,
inventions, know-how (including trade secrets and other unpatented
or unpatentable or confidential information, systems, or
procedures), trademarks, service marks, trade names, copyrights and
other intellectual property rights (collectively, the
“Intellectual Property”) necessary for the conduct
of its business as described in each of the General Disclosure
Package and the Prospectus, except as would not reasonably be
expected to have a Material Adverse Effect. No claims have
been asserted against the Company by any person with respect to the
use of any such Intellectual Property or challenging or questioning
the validity or effectiveness of any such Intellectual Property
except as would not reasonably be expected to have a Material
Adverse Effect.
(s)
Each of the Company and its
Subsidiaries is in compliance with all applicable laws,
rules and regulations of the jurisdictions in which it is
conducting business, including, without limitation, all applicable
local, state and federal banking and environmental laws and
regulations, except where failure to be so in compliance would not
reasonably be expected to have a Material Adverse Effect.
Except as described in the General Disclosure Package and the
Prospectus, neither the Company nor any of its Subsidiaries is
(a) in violation of its charter or bylaws or other
organizational documents, as applicable, except for any immaterial
failure on the part of the Subsidiaries (other than the Bank) to
comply; (b) is in default under, and no event has occurred
which, with notice or lapse of time or both, would constitute such
a default or result in the creation or imposition of any lien,
charge, or encumbrance upon any property or assets of the Company
or any of its Subsidiaries, pursuant to any agreement, mortgage,
deed of trust, lease, franchise, license, indenture or permit,
except as would not reasonably be expected to have a Material
Adverse Effect or (c) a party to or subject to or has received
any order, decree, agreement, memorandum of understanding or
similar arrangement with, or a commitment letter, supervisory
letter or similar submission to, any governmental authority, and
neither the Company nor any Subsidiary has been advised by any
governmental authority that such governmental authority is
contemplating issuing or requesting (or is
7
considering the appropriateness of issuing or
requesting) any such order, decree, agreement, memorandum of
understanding, commitment letter, supervisory letter or similar
submission. Neither the Company nor any Subsidiary has
received any communication from any governmental authority that it
is not acting in material compliance with any statute, regulation
or ordinance. The Bank has received a Community Reinvestment
Act rating of “Satisfactory” or better.
(t)
Each of the Company and its
Subsidiaries has filed on a timely basis (giving effect to
extensions) all required federal, state and foreign income and
franchise tax returns and has paid or accrued all taxes shown as
due thereon to the extent that such taxes have become due and are
not being contested in good faith, and the Company does not have
knowledge of any tax deficiency that has been or might be asserted
or threatened against it or any Subsidiary, in each case, that
could reasonably be expected to have a Material Adverse Effect.
All material tax liabilities accrued through the date hereof
have been adequately provided for on the books of the
Company. There is no tax lien, whether imposed by any
federal, state or other taxing authority, outstanding against the
assets of the Company or any of its Subsidiaries that would
reasonably be expected to have a Material Adverse
Effect.
(u)
On the Settlement Date, all stock
transfer or other taxes (other than income taxes) that are
required to be paid in connection with the sale and transfer of the
Shares will have been, fully paid or provided for by the Company
and all laws imposing such taxes will have been fully complied
with.
(v)
The Company is not and, after giving
effect to the offering and sale of the Shares and the application
of the proceeds thereof, will not be an “investment
company,” as such term is defined in the Investment Company
Act of 1940, as amended.
(w)
The Company and each of its
Subsidiaries maintain insurance underwritten by insurers of
recognized financial responsibility, of the types and in the
amounts that the Company reasonably believes is adequate for its
business on a consolidated basis, including, but not limited to,
insurance covering real and personal property owned or leased by
the Company or any of its Subsidiaries against theft, damage,
destruction, acts of vandalism and all other risks customarily
insured against, with such deductibles as are customary for
companies in the same or similar business, all of which insurance
is in full force and effect. There are no material claims by
the Company or any Subsidiary under any such policy or instrument
as to which any insurance company is denying liability or defending
under a reservation of rights clause. Neither the Company nor
any Subsidiary has received notice from any insurance carrier that
such insurance will be canceled or that coverage thereunder will be
reduced or eliminated (except any such insurance or coverage that
will be replaced by policies covering the full or substantially the
full amount of the original coverage with no lapse in coverage),
and there are presently no material claims pending under policies
of such insurance and no notices have been given by the Company or
any Subsidiary under such policies.
(x)
Neither the Company nor any
affiliate of the Company nor any person acting on their behalf has
taken, nor will the Company or any affiliate or any person acting
on their behalf take, directly or indirectly, any action which is
designed to or which has constituted
8
or which would reasonably be expected to cause
or result in stabilization or manipulation of the price of any
security of the Company to facilitate the sale or resale of the
Shares.
(y)
The Company shall use the net
proceeds received by it from the sale of the Shares pursuant to
this Agreement in the manner specified in each of the General
Disclosure Package and the Prospectus under the caption “Use
of Proceeds.”
(z)
No transaction has occurred between
or among the Company or any Subsidiary, on the one hand, and its
affiliates, officers or directors on the other hand, that is
required to have been described under applicable securities laws in
its 1934 Act filings and is not so described in such
filings.
(aa)
There is no transaction, arrangement
or other relationship between the Company or any of its
Subsidiaries and an unconsolidated or other off-balance sheet
entity that is required to be disclosed by the Company in its 1934
Act filings and is not so disclosed or that otherwise would be
reasonably expected to have a Material Adverse Effect.
(bb)
Each of the Company and its
Subsidiaries has all franchises, licenses, certificates and other
authorizations from such federal, state or local government or
governmental agency, department or body that are currently
necessary to own, lease and operate their respective properties and
currently necessary for the operation of their respective
businesses, except where the failure to possess currently such
franchises, licenses, certificates and other authorizations would
not reasonably be expected to have a Material Adverse Effect.
Neither the Company nor any Subsidiary has received any notice of
proceedings relating to the revocation or modification of any such
permit that, if the subject of an unfavorable decision, ruling or
finding, could reasonably be expected to have a Material Adverse
Effect.
(cc)
The consolidated financial
statements of the Company and the related notes and schedules
thereto included in its 1934 Act filings fairly present the
financial position, results of operations, shareholders’
equity and cash flows of the Company and its consolidated
Subsidiaries at the dates and for the periods specified
therein. Such financial statements and the related notes and
schedules thereto have been prepared in accordance with accounting
principles generally accepted in the United States consistently
applied throughout the periods involved (except as otherwise noted
therein) and all adjustments necessary for a fair presentation
of results for such periods have been made; provided ,
however , that the unaudited financial statements are
subject to normal year-end audit adjustments (which are not
expected to be material) and do not contain all footnotes
required under generally accepted accounting principles.
(dd)
The Company is in compliance in all
material respects with the requirements of the New York Stock
Exchange (“ NYSE ”) for continued listing
of the Common Stock thereon. The Company has taken no action
designed to, or likely to have the effect of, terminating the
registration of the Common Stock under the 1934 Act or the listing
of the Common Stock on the NYSE, nor has the Company received any
notification that the Commission or NYSE is contemplating
terminating such registration or listing. The transactions
contemplated by this Agreement will not contravene the
rules and regulations of NYSE.
9
(ee)
The Company maintains a system of
internal controls over financial reporting (as defined in
Rule 13a-15 under the 1934 Act) that have been designed
by, or under the supervision of, its principal executive and
financial officer, to provide reasonable assurance that
(i) transactions are executed in accordance with
management’s general or specific authorization;
(ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with generally
accepted accounting principles and to maintain accountability for
assets; (iii) access to assets is permitted only in accordance
with management’s general or specific authorization; and
(iv) the recorded accountability for assets is compared with
existing assets at reasonable intervals and appropriate action is
taken with respect to any differences. The Company has
disclosure controls and procedures (as defined in Rules 13a-4
and 15d-14 under the 1934 Act) that are designed to ensure
that material information relating to the Company is made known to
the Company’s principal executive officer and the
Company’s principal financial officer or persons performing
similar functions. The Company has not become aware of any
fraud, whether or not material, that involves management or other
employees who have a significant role in the Company’s
internal control over financial reporting. The Company is
otherwise in compliance in all material respects with all
applicable provisions of the Sarbanes-Oxley Act of 2002, as amended
and the rules and regulations promulgated
thereunder.
(ff)
Neither the Company, nor any
Subsidiary, nor, to the knowledge of the Company, any director,
officer, agent, employee or other Person acting on behalf of the
Company or any Subsidiary has, in the course of its actions for, or
on behalf of, the Company (i) used any corporate funds for any
unlawful contribution, gift, entertainment or other unlawful
expenses relating to political activity; (ii) made any direct
or indirect unlawful payment to any foreign or domestic government
official or employee from corporate funds; (iii) violated or
is in violation of any provision of the U.S. Foreign Corrupt
Practices Act of 1977, as amended; or (iv) made any unlawful
bribe, rebate, payoff, influence payment, kickback or other
unlawful payment to any foreign or domestic government official or
employee.
(gg)
Except as described in each of the
General Disclosure Package and the Prospectus, (A) there are
no outstanding rights (contractual or otherwise), warrants or
options to acquire, or instruments convertible into or exchangeable
for, or agreements with respect to the sale or issuance of, any
shares of capital stock of or other equity interest in the Company
(other than this Agreement) and (B) there are no
agreements between the Company and any person granting such person
the right to require the Company to file a registration statement
under the 1933 Act or otherwise register any securities of the
Company owned or to be owned by such person.
(hh)
Except as described in the
Prospectus, the Company is in compliance in all material respects
with all presently applicable provisions of the Employee Retirement
Income Security Act of 1974, as amended, including the regulations
and published interpretations thereunder (herein called “
ERISA ”); no “reportable event” (as
defined in ERISA) has occurred with respect to any
“pension plan” (as defined in ERISA) for which the
Company would have any material liability; the Company has not
incurred and does not expect to incur any material liability under
(i) Title IV of ERISA with respect to termination of, or
withdrawal from, any “pension plan”; or
(ii) Sections 412 or 4971 of the Internal Revenue Code of
1986, as amended, including the regulations and published
interpretations thereunder (the “ Code ”); and
each
10
“Pension Plan” for which the Company
would have liability that is intended to be qualified under
Section 401(a) of the Code is so qualified in all
material respects and nothing has occurred, whether by action or by
failure to act, which would cause the loss of such
qualification.
(ii)
There has been no storage, disposal,
generation, manufacture, transportation, handling or treatment of
toxic wastes, hazardous wastes or hazardous substances by the
Company or any Subsidiary (or, to the knowledge of the Company, any
of their predecessors in interest) at, upon or from any of the
property now or previously owned or leased by the Company or any
Subsidiary in violation of any applicable law, ordinance, rule,
regulation, order, judgment, decree or permit or that would require
remedial action under any applicable law, ordinance, rule,
regulation, order, judgment, decree or permit; there has been no
material spill, discharge, leak, emission, injection, escape,
dumping or release of any kind into such property or into the
environment surrounding such property of any toxic wastes, medical
wastes, solid wastes, hazardous wastes or hazardous substances due
to or caused by the Company or any Subsidiary or with respect to
which the Company or any Subsidiary have knowledge; in each of the
foregoing cases, except as would not reasonably be expected to have
a Material Adverse Effect. As used in this
Section 1(ii), the terms “hazardous wastes”,
“toxic wastes”, “hazardous substances”, and
“medical wastes” shall have the meanings specified in
any applicable local, state, federal and foreign laws or
regulations with respect to environmental protection.
(jj)
The Company is not, nor has ever
been, a U.S. real property holding corporation within the meaning
of Section 897 of the Internal Revenue Code of 1986, as
amended.
(kk)
The Company is not, nor has ever
been, an issuer of the type described in
Rule 144(i)(l) under the 1933 Act.
(ll)
Each of the Company and its
Subsidiaries does and will, after giving effect to the transactions
contemplated hereby, own assets the fair saleable value of which
are (i) greater than the total amount of its liabilities
(including known contingent liabilities) and (ii) greater
than the amount that will be required to pay the probable
liabilities of its existing debts as they become absolute and
matured considering the financing alternatives reasonably available
to it. The Company has no knowledge of any facts or
circumstances which lead it to believe that it or any of its
Subsidiaries will be required to file for reorganization or
liquidation under the bankruptcy or reorganization laws of any
jurisdiction, and has no present intent to so file.
(mm)
Neither the execution of this
Agreement nor the issuance of the Shares will trigger any rights or
obligations, or require compliance with any Hawaii
“takeover” statute.
Section 2.
Sale and Delivery of
Shares .
(a)
Subject to the terms and conditions
set forth herein, the Company agrees to sell through the Agents,
acting as sales agents, or directly to the Agents, acting as
principals, from time to time, and the Agents agree to use their
commercially reasonable efforts to sell, as sales agents for the
Company, the Shares. Sales of the Shares, if any, through the
Agents acting as sales agents or directly to the Agents, acting as
principals, will be made by means of ordinary
11
brokers’ transactions on the NYSE or
otherwise at market prices prevailing at the time of sale, at
prices related to prevailing market prices or at negotiated
prices.
(b)
The Shares are to be sold on a daily
basis or otherwise as shall be agreed to by the Company and the
Agent that is the exclusive sales Agent for the sale of the Shares,
pursuant to Section 2(c) below (the “
Exclus